Skip to main content
Premium Trial:

Request an Annual Quote

Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform

NEW YORK – Breast care software firm Volpara Health said Thursday that it has signed an agreement with Invitae to bring Invitae's genetic testing services to Volpara's customers in the US.

Under the agreement, Wellington, New Zealand-based Volpara will create an integrated ordering process for Invitae genetic testing services within its suite of products. Customers using Volpara's breast cancer risk assessment software will be able to triage patients to supplemental imaging and/or genetic testing based on their personalized risk.

Financial terms were not disclosed.

Volpara CEO Ralph Highnam said in a statement that the move will allow the company to offer increased value to customers.

"While the value of genetic information in cancer care is well established, the ability to combine genetics with breast density and other forms of risk assessment to guide patient care remains underutilized," added Robert Nussbaum, Invitae's chief medical officer. "In working with Volpara, we want to make it easier for clinicians and oncologists to access genetic testing services to ensure that their patients have comprehensive and personalized medical information to better inform their healthcare decisions."

Volpara previously announced a similar integration agreement with Ambry Genetics.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.